ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination and Myocardial Infarction

ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination has been researched along with Myocardial Infarction in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andersson, M; Elgen, K; Hagman, A; Larsson, L; Leward, S; Wolff, T	1

Trials

1 trial(s) available for ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination and Myocardial Infarction

Article	Year
Analgesic treatment in acute myocardial infarction. A double-blind comparison of ketobemidone + the spasmolytic A29 (Ketogan) and morphine. Acta medica Scandinavica, 1988, Volume: 223, Issue:5 Topics: Adult; Aged; Allylamine; Amines; Analgesics, Opioid; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Meperidine; Middle Aged; Morphine; Myocardial Infarction; Parasympatholytics	1988

Article

Year

Analgesic treatment in acute myocardial infarction. A double-blind comparison of ketobemidone + the spasmolytic A29 (Ketogan) and morphine.

Acta medica Scandinavica, 1988, Volume: 223, Issue:5

Topics: Adult; Aged; Allylamine; Amines; Analgesics, Opioid; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Meperidine; Middle Aged; Morphine; Myocardial Infarction; Parasympatholytics

1988